LMC Diabetes & Endocrinology’s Presents Type 2 Diabetes Findings at #EASD2016 in Munich, Germany

LMC Diabetes & Endocrinology’s Presents Type 2 Diabetes Findings at #EASD2016 in Munich, Germany

During the week of September 12th – 16th, 2016, LMC Diabetes & Endocrinology’s Dr. Ronnie Aronson and Dr. Harpreet Bajaj were present at the 52nd EASD Annual Meeting hosted by the European Association for the Study of Diabetes in Munich, Germany. The EASD is a non-profit association of scientists, physicians, laboratory workers, nurses and students who are interested in diabetes and related subjects.

Not only did both of LMC’s endocrinologists have key information to share via poster presentations, Dr. Bajaj also gave an oral presentation titled:Canagliflozin and dapagliflozin, but not liraglutide, reduce Alanine Aminotransferase (ALT) levels in type 2 diabetes: a difference not explained by HbA1c or weight change.

To view this presentation, click here: http://m.easdvirtualmeeting.org/#Presentations/29238/Webcast

To learn more about LMC, visit their website here.

Submit a Comment

Your email address will not be published. Required fields are marked *